Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 2315Neoplasms 1678Prostatic Neoplasms 1178Lung Neoplasms 908Colorectal Neoplasms 873Carcinoma, Non-Small-Cell Lung 848Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 510Brain Neoplasms 509Neoplasm Metastasis 456Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 397Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 355Squamous Cell Carcinoma of Head and Neck 355Rectal Neoplasms 336Recurrence 332Hematologic Neoplasms 323Sarcoma 322Colonic Neoplasms 316Lymphoma 310Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Glioma 277Carcinoma, Renal Cell 277

Interventions

Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Solid Cancers × 1 year × Clear all
NCT07510841 2026-04-06

JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

Biotech Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
228 enrolled

Solid Cancers

NCT07427186 2026-02-25

MINER2

Institut Claudius Regaud

Phase NA Not yet recruiting
600 enrolled

Solid Cancers

NCT03514368 2026-02-19

MINER

Institut Claudius Regaud

Phase NA Recruiting
770 enrolled

Solid Cancers

NCT07170293 2025-09-12

Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors

Tianjin Medical University Second Hospital

Phase 2 Recruiting
15 enrolled

Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡